Company research
Arbor Rapha Capital Bioholdings Corp. I
CIK 1855886Updated Sep 24, 2026
Securities
ARCK price & chart
Historical security
This listing closed Mar 7, 2023. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2021 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2021 |
|---|---|
| ASSETS | |
| AssetsUSD | 178,890,791Source |
| Current assets: | |
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,344,116Source |
| Assets, CurrentUSD | 1,750,616Source |
| LIABILITIES AND EQUITY | |
| LiabilitiesUSD | 10,647,705Source |
| Stockholders’ equity: | |
| Retained Earnings (Accumulated Deficit)USD | -8,569,845Source |
| Stockholders' Equity Attributable to ParentUSD | -8,569,414Source |
| Liabilities and EquityUSD | 178,890,791Source |
| Current liabilities: | |
| Liabilities, CurrentUSD | 297,705Source |
cash flow · annual statements
| Line item | FY 2021 |
|---|---|
| Cash flows from operating activities: | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 496,692Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -933,162Source |
| Cash flows from investing activities: | |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -176,812,500Source |
| Cash flows from financing activities: | |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 179,089,778Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 1,344,116Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,344,116Source |
| Additional Financial Items | |
| Investment Income, InterestUSD | 2,922Source |
| Net Income (Loss) Attributable to ParentUSD | -496,692Source |
| Nonoperating Income (Expense)USD | 2,922Source |
| Operating Costs and ExpensesUSD | 499,614Source |
| Proceeds from Issuance of Common StockUSD | 25,000Source |
income statement · annual statements
| Line item | FY 2021 |
|---|---|
| Operating Income (Loss)USD | -499,614Source |
| Net Income (Loss) Attributable to ParentUSD | -496,692Source |
| Additional Financial Items | |
| Investment Income, InterestUSD | 2,922Source |
| Nonoperating Income (Expense)USD | 2,922Source |
| Operating Costs and ExpensesUSD | 499,614Source |